Investors in Amgen Inc. AMGNneed to pay close attention to the stock based on moves in the options market lately. That is because the March 2nd, 2017 $170 Call had some of the highest implied volatility of all equity options today. What is …
co will make upfront payment of $40 million and purchase $20 million of cytomx common stock.CytomX will be eligible to receive up to $455 million in development, regulatory and commercial milestones for EGFR program.CytomX to be able …
The stock price of Amgen, Inc. (NASDAQ:AMGN) climbed 6% to $157.19 per share after the company disclosed its plans to increase its shareholders dividend by 30% in the first quarter and to buyback approximately $2 billion worth of shares …
Based on fundamentals, market trends, company events and news, and other factors, equity analysts assign price targets and recommendations to buy or sell a stock. The following graph shows how a survey of multiple analysts recommend …
We expect shares to trade off on the elevated expenses though the stock market was arguably prepared for it with ... and 3.8% dividend yield. Amgen (AMGN): Reiterate outperform rating. Remain buyers after a solid fourth quarter beat and …
Amgen Inc on Thursday reported a fourth-quarter profit well below Wall Street estimates, hurt by a steep decline in sales of blockbuster rheumatoid arthritis drug Enbrel and higher-than-expected expenses, and its shares fell nearly 2 percent. …
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq: AMGN), bought Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) in a $10.4 billion dollar deal – making it the fifth-largest biotech deal in history …